Posterior reversible encephalopathy and Guillain-Barré syndrome in a single patient: Coincidence or causative relation?

Clinical Neurology and Neurosurgery

Volumn 109, Issue 1, 2007, Pages 58-62

  Van Diest, D ^a,b   Van Goethem, J W M ^c   Vercruyssen, A ^a   Jadoul, C ^a   Cras, P ^b  

^a Maria Middelares Hospital   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c AZ Maria Middelares ^*  (Belgium)

Author keywords

Guillain Barr syndrome; Hypertensive encephalopathy; Posterior reversible encephalopathy syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYTOKINE; IMMUNOGLOBULIN; LABETALOL; MORPHINE; PARACETAMOL; PIRITRAMIDE; TRAMADOL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARM WEAKNESS; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD BRAIN BARRIER; BRAIN DISEASE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; ECHOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LABORATORY TEST; LITERATURE; LUMBAR PUNCTURE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; RADIODIAGNOSIS; RISK FACTOR; SCAPULAR PAIN; SYMPTOM; TONIC CLONIC SEIZURE;

BRAIN DISEASES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MIDDLE AGED; SYNDROME;

EID: 33845296469     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2006.01.004     Document Type: Article

References (21)

1. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A., et al. A reversible posterior reversible leukoencephalopathy syndrome. N Engl J Med 334 (1996) 494-500
2. Parizel P.M., Snoeck H.W., van den Hauwe L., Boven K., Bosmans J.L., Van Goethem J.W., et al. Cerebral complications of murine monoclonal CD3 antibody (OKT3): CT and MR findings. Am J Neuroradiol 18 (1997) 1935-1938
3. Kastrup O., Maschke M., Wanke I., and Diener H.C. Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 249 (2002) 1563-1566
4. Mathy I., Gille M., Van Raemdonck F., Delbecq J., and Depre A. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 98 (1998) 347-351
5. Voltz R., Rosen F.V., Yousry T., Beck J., and Hohlfeld R. Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin. Neurology 46 (1996) 250-251
6. Harkness K., Howell S.J., and Davies-Jones G.A. Encephalopathy associated with intravenous immunoglobulin treatment for Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 60 (1996) 586
7. Doss-Esper C.E., Singhal A.B., Smith M.S., and Henderson G.V. Reversible posterior leukoencephalopathy, cerebral vasoconstriction, and strokes after intravenous immune globulin therapy in Guillain-Barré syndrome. J Neuroimaging 15 (2005) 188-192
8. Lamy C., Oppenheim C., Meder J.F., and Mas J.L. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 14 (2004) 89-96
9. Schwartz R.B., Mulkern R.V., Gudbjartsson H., and Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. Am J Neuroradiol 19 (1998) 859-862
10. Casey S.O., Sampaio R.C., Michel E., and Truwit C.L. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21 (2000) 1199-1206
11. Schwartz R.B., Feske S.K., Polak J.F., DeGirolami U., Iaia A., Beckner K.M., et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates ands insights into the pathogenesis of hypertensive encephalopathy. Radiology 217 (2000) 371-376
12. Servillo G., Striano P., Striano S., Tortora F., Boccella P., De Robertis E., et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 29 (2003) 2323-2326
13. Lichtenfield P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 50 (1971) 772-780
14. Ropper A.H. The Guillain-Barré syndrome. N Engl J Med 326 (1992) 1130-1136
15. Del Giudice E., and Aicardi J. Atypical aspects of hypertensive encephalopathy in childhood. Neuropediatrie 10 (1979) 150-157
16. Okada T., Hiyoshi K., Noto N., Fujita Y., Fuchigami T., Okubo O., et al. A case of Guillain-Barré syndrome accompanied by sympathetic overactivity and hypertensive encephalopathy. Acta Paediatr 85 (1996) 1006-1008
17. Dixon S.F., Appleton R.E., Davidson J.E., Hughes D.A., and Tedman B.M. Acute, severe self-limiting dysautonomia and hypertensive encephalopathy. Pediatr Neurol 25 (2001) 319-324
18. Elahi A., Kelkar P., and St Louis E.K. Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome. Neurocrit Care 1 (2004) 465-468
19. Takano T., Ohno M., Takeuchi Y., Mandai R., and Yoshida S. Cytotoxic edema and interleukin-6 in hypertensive encephalopathy. Pediatr Neurol 26 (2002) 71-73
20. Kieseier B.C., Tani M., Mahad D., Oka N., Ho T., Woodroofe N., et al. Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125 (2002) 823-834
21. Wong D., Dorovini-Zis K., and Vincent S.R. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol 190 (2004) 446-455